Liver Cancer
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2006; 12(39): 6290-6298
Published online Oct 21, 2006. doi: 10.3748/wjg.v12.i39.6290
Table 1 Retrospective study of enhancement patterns of hepatic tumors
Hepatocellular carcinoman =178M etastasisn =56Hemangioman =69
Arterial phase
A195% (169/178)9% (5/56)0% (0/69)
A21% (1/178)27% (15/56)1% (1/69)
A30% (0/178)55% (31/56)0% (0/69)
A41% (2/178)0% (0/56)61% (42/69)
A53% (6/178)9% (5/56)38% (26/69)
Portal phase
P193% (166/178)16% (9/56)46% (32/69)
P24% (8/178)14% (8/56)0% (0/69)
P31% (2/178)66% (37/56)1% (1/69)
P41% (2/178)4% (2/56)52% (36/69)
Late Phase
L18% (14/178)0% (0/56)20% (14/69)
L292% (164/178)100% (56/56)80% (55/69)